{"id":"https://openalex.org/W2401256155","doi":null,"title":"The role of angiogenesis in the biology and therapy of myelodysplastic syndromes.","display_name":"The role of angiogenesis in the biology and therapy of myelodysplastic syndromes.","alternate_titles":[],"publication_year":2004,"publication_date":"2004-05-01","ids":{"openalex":"https://openalex.org/W2401256155","mag":"2401256155","pmid":"https://pubmed.ncbi.nlm.nih.gov/15087066"},"language":"en","primary_location":{"id":"pmid:15087066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15087066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current hematology reports","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2401256155"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110317452","display_name":"\u00c1lvaro Aguayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097900","display_name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","ror":"https://ror.org/00xgvev73","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210097900","https://openalex.org/I4210128723"]}],"countries":["MX"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alvaro Aguayo","raw_affiliation_strings":["Department of Hematology and Oncology, National Institute of Medical Sciences and Nutrition Salvador Zubir\u00e1n, Vasco de Quiroga 15, Tlalpan, CP 14000, Mexico City, Mexico. alvaroaguayo01@aol.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, National Institute of Medical Sciences and Nutrition Salvador Zubir\u00e1n, Vasco de Quiroga 15, Tlalpan, CP 14000, Mexico City, Mexico. alvaroaguayo01@aol.com","institution_ids":["https://openalex.org/I4210097900"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110317452"],"corresponding_institution_ids":["https://openalex.org/I4210097900"],"apc_list":null,"apc_paid":null,"fwci":2.1649,"has_fulltext":false,"cited_by_count":26,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86477536,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"3","issue":"3","first_page":"184","last_page":"191"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.5903000235557556,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.5903000235557556,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.3944999873638153,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9900000095367432},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.8980000019073486},{"id":"https://openalex.org/keywords/su5416","display_name":"SU5416","score":0.9620000123977661},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/arsenic-trioxide","display_name":"arsenic trioxide","score":0.996999979019165},{"id":"https://openalex.org/keywords/metalloproteinase-inhibitors","display_name":"metalloproteinase inhibitors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/ineffective-hematopoiesis","display_name":"ineffective hematopoiesis","score":0.8190000057220459},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.527999997138977},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.7950000166893005},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.36800000071525574},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.8809202909469604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8027321100234985},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.6784361600875854},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.5091833472251892},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49933719635009766},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.45369911193847656},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40884503722190857},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.37786951661109924},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.10557922720909119},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15087066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15087066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current hematology reports","raw_type":"Journal Article"},{"id":"mag:2401256155","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15087066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2073461622","https://openalex.org/W1999524218","https://openalex.org/W2034711081","https://openalex.org/W2416472819","https://openalex.org/W2370129823","https://openalex.org/W2376480370","https://openalex.org/W2047708963","https://openalex.org/W98275235","https://openalex.org/W2094022450","https://openalex.org/W2389714699"],"abstract_inverted_index":{"Myelodysplastic":[0],"syndromes":[1],"(MDS)":[2],"are":[3,102,113],"a":[4,17,56],"group":[5],"of":[6,16,29,50,62,86,111,151,154,160],"hematologic":[7,63,97],"disorders":[8],"characterized":[9],"by":[10],"peripheral":[11],"cytopenias":[12],"in":[13,37,59,70,165],"the":[14,60,81,84,100,118,125,152,158],"setting":[15],"normocellular":[18],"or":[19],"hypercellular":[20],"bone":[21],"marrow":[22],"that":[23],"morphologically":[24],"shows":[25],"trilineage":[26],"dysplasia.":[27],"Mechanisms":[28],"disease":[30],"include":[31],"pluripotent":[32],"stem":[33],"cell":[34],"damage,":[35],"abnormalities":[36],"proliferation,":[38],"differentiation,":[39],"and":[40,68,72,77,92,139,157],"apoptosis":[41,78],"leading":[42],"to":[43,147],"an":[44,149],"ineffective":[45],"hematopoiesis.":[46],"A":[47],"growing":[48],"body":[49],"evidence":[51,153],"support":[52],"angiogenesis":[53,71,156,164],"as":[54,90,117,137],"having":[55],"key":[57],"role":[58],"pathophysiology":[61],"malignancies,":[64],"including":[65],"MDS.":[66,168],"Knowledge":[67],"interest":[69],"its":[73,93],"interactions":[74],"with":[75,96,106,167],"proliferation":[76],"have":[79],"provided":[80],"rationale":[82],"for":[83],"use":[85],"antiangiogenic":[87,109],"drugs,":[88],"such":[89,116,136],"thalidomide":[91],"analogue":[94],"CC5013,":[95],"improvement.":[98],"Although":[99],"results":[101],"modest,":[103],"other":[104],"drugs":[105],"somewhat":[107],"novel":[108],"mechanisms":[110],"action":[112],"under":[114],"development,":[115],"vascular":[119],"endothelial":[120,127],"growth":[121,128],"factor-receptor":[122],"blocker":[123],"SU5416,":[124],"antivascular":[126],"factor":[129],"antibody":[130],"bevacizumab,":[131],"arsenic":[132],"trioxide,":[133],"metalloproteinase":[134],"inhibitors,":[135],"AG3340,":[138],"farnesyl":[140],"transferase":[141],"inhibitor":[142],"R115777.":[143],"This":[144],"review":[145],"attempts":[146],"provide":[148],"overview":[150],"increased":[155],"status":[159],"drug":[161],"development":[162],"targeting":[163],"patients":[166]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2401256155","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
